Welcome to LookChem.com Sign In|Join Free

CAS

  • or

335672-28-1

Post Buying Request

335672-28-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

335672-28-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 335672-28-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,5,6,7 and 2 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 335672-28:
(8*3)+(7*3)+(6*5)+(5*6)+(4*7)+(3*2)+(2*2)+(1*8)=151
151 % 10 = 1
So 335672-28-1 is a valid CAS Registry Number.

335672-28-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-(2-formyl-3-methoxyphenyl)carbamate

1.2 Other means of identification

Product number -
Other names tert-butyl 2-formyl-3-methoxyphenylcarbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:335672-28-1 SDS

335672-28-1Downstream Products

335672-28-1Relevant articles and documents

Preparation method of arylamine o-substituted compound

-

Paragraph 0083-0085, (2019/11/13)

The invention discloses a preparation method of an arylamine o-substituted compound as shown in a formula I in the specification. The preparation method provided by the invention comprises the following steps: (1) in a continuous flow reactor, carrying ou

Rational design of central selective acetylcholinesterase inhibitors by means of a "bio-oxidisable prodrug" strategy

Bohn, Pierre,Le Fur, Nicolas,Hagues, Guillaume,Costentin, Jean,Torquet, Nicolas,Papamicael, Cyril,Marsais, Francis,Levacher, Vincent

experimental part, p. 2612 - 2618 (2009/10/30)

This work deals with the design of a "bio-oxidisable prodrug" strategy for the development of new central selective acetylcholinesterase inhibitors. This prodrug approach is expected to reduce peripheral anticholinesterase activity responsible for various

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 335672-28-1